Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Merck's Keytruda shown to extend lung cancer survival in two trials [Reuters (UK)]

Merck & Company, Inc. (new) (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
Company Research Source: Reuters
Merck's Keytruda shown to extend lung cancer survival in two trials | Reuters 4 Min Read CHICAGO (Reuters) - New trial results show that Merck & Co’s Keytruda improves survival as a stand-alone treatment for newly diagnosed lung cancer and in combination with chemotherapy for hard-to-treat squamous cell lung cancer. The results, presented at the annual meeting of the American Society for Clinical Oncology in Chicago, add to the argument that Keytruda has “set the floor against which other therapies will need to be compared,” Roy Baynes, head of clinical development at Merck, told Reuters. Keytruda, along with drugs like Roche’s Tecentriq and Bristol-Myers Squibb’s Opdivo, is designed to unleash the body’s immune system to attack cancer cells. One trial involved 1,274 patients with advanced non-small cell lung cancer who tested positive for the PDL1 protein targeted by Keytruda. It showed that Keytruda patients lived for a median of 16.7 months, compared with 12.1 percent for patients Show less Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
MRK alerts

from News Quantified
Opt-in for
MRK alerts

from News Quantified